Causes and Risk Factors for Chronic Myeloid Leukemia
Chronic myeloid leukemia (CML) is caused by a specific acquired genetic change in blood-forming cells that alters how white blood cells grow and divide. The condition typically progresses slowly and is most often diagnosed in middle-aged and older adults, though it can occur at any stage of life. Understanding why CML develops helps patients and caregivers better grasp who is most likely to be affected and which factors, if any, contribute to its development.
Key Takeaways
- Chronic myeloid leukemia (CML) begins with an acquired genetic change — the BCR-ABL1 fusion gene, carried on the Philadelphia chromosome — not an inherited one.
- Most people with CML have no identifiable external trigger; the change occurs randomly in a single bone marrow cell during a person’s lifetime.
- Older age and, less commonly, prior exposure to high-dose ionizing radiation are the only well-established risk factors.
- CML is rare in children and arises through the same genetic mechanism seen in adults, with no confirmed pediatric-specific risk factors identified.
The Primary Biological Cause of Chronic Myeloid Leukemia
At the cellular level, CML is driven by a chromosomal abnormality that affects how bone marrow cells function. In most patients, parts of chromosomes 9 and 22 swap places, creating an abnormal fusion gene that keeps sending signals for white blood cell production. As abnormal cells accumulate, they crowd out normal blood cells, which is what ultimately produces the disease.
This chromosomal change happens after birth, inside a single bone marrow cell, rather than being present from conception. For that reason, CML is classified as an acquired (somatic) change rather than a hereditary condition.
Genetic Mechanisms Behind CML Development
The genetic alteration behind CML directly disrupts the signaling that normally controls cell growth and survival. The abnormal protein it produces stays continuously active, so affected cells keep dividing and largely avoid the normal process of programmed cell death.
Because the abnormal cells still function and mature to some degree, especially early on, CML tends to progress slowly at first, and initial symptoms are often mild or absent. As the disease advances, additional genetic changes — discussed further below — can accumulate on top of the original alteration and drive it toward a more aggressive phase.
Is Chronic Myeloid Leukemia Inherited?
Many people ask whether CML runs in families. It generally does not: the genetic change responsible for the disease is absent at conception, and a parent cannot hand it down to a child. Instead, it arises spontaneously in a bone marrow cell at some point during a person’s life, a type of change known as a somatic mutation.
Because the change is acquired rather than inherited, CML is not currently classified among the hereditary cancer syndromes that run in families, which is a helpful distinction for patients and families weighing the value of genetic counseling.
Known Risk Factors Associated With CML
The list of confirmed CML risk factors is short: older age and exposure to high doses of ionizing radiation. Unlike many other cancers, factors such as diet, smoking, and physical activity do not currently appear among the recognized risk factors for CML.
Radiation-related risk typically stems from high-dose exposure, such as radiation therapy previously given for another condition (for example, thyroid cancer or Hodgkin lymphoma) or, less commonly, a large-scale radiation event such as a nuclear disaster. It generally takes many years for leukemia to develop after radiation exposure, and most people who receive radiation treatment never develop it. Consistent with this, most people diagnosed with CML have no history of radiation exposure at all — radiation is a recognized contributor, not a common one.
Age and Demographic Patterns in CML
CML is primarily a disease of middle-aged and older adults. The median age at diagnosis is 67, and the disease is most frequently diagnosed between ages 65 and 74. As bone marrow cells divide repeatedly over decades, the odds of acquiring the genetic change appear to rise, which may help explain why CML is uncommon before middle age.
CML also shows a modest male predominance: according to SEER data from the National Cancer Institute, age-adjusted rates put the annual rate at about 2.7 new cases per 100,000 men, compared with about 1.6 per 100,000 women. Why the sexes differ this way isn’t well explained. These are population-level patterns, not a prediction of any one person’s individual risk.
Childhood and Pediatric Chronic Myeloid Leukemia
CML occurs mainly in middle-aged and older adults but can also occur in children, where it remains rare: according to SEER Cancer Stat Facts, people younger than 20 account for roughly 1.6% of new CML diagnoses. In pediatric cases, the same BCR-ABL1 genetic change found in adults is responsible for the disease.
Risk factors in pediatric CML are not well defined, since most affected children have no known radiation exposure or other identifiable trigger. As in adults, pediatric cases are considered sporadic, meaning they occur without a predictable cause rather than through a preventable one.
For most people diagnosed with CML at any age, the exact trigger for the chromosomal change is never identified. Because the alteration can arise from a random error during normal cell division, there is no reliable way to foresee or head off CML in a given person, and routine screening is not performed in people without symptoms.
Understanding the Underlying Cellular Abnormality
From a molecular standpoint, CML is defined by a reciprocal chromosomal translocation, in which chromosome 9 and chromosome 22 trade segments, fusing the ABL1 and BCR genes into one abnormal gene commonly called BCR-ABL1. The chromosome that ends up carrying this fusion gene is known as the Philadelphia chromosome and, per the National Cancer Institute, shows up in more than 95% of people with CML, making it a defining feature of the disease.
According to MedlinePlus, in the remaining 5% to 10% of cases, a more complex rearrangement involving additional chromosomes produces the same BCR-ABL1 fusion gene through what is called a variant Philadelphia translocation; these cases behave similarly to the more typical form. The Philadelphia chromosome also provides a specific molecular target that modern CML therapies are designed around.
Broader Perspective on Disease Origin
Separating the direct biological cause of CML from its contributing risk factors is useful context: the disease always begins with the BCR-ABL1 change, but why that change occurs in one person and not another usually cannot be explained. As the disease progresses, additional genetic changes — including a duplicated chromosome 8, a structural change to chromosome 17, or a second copy of the Philadelphia chromosome itself — are often found layered on top of the original alteration and are thought to contribute to more advanced disease.
Pediatric-Specific Causes and Risks
Families of children diagnosed with CML often want to understand what caused it. The disease begins with the same chromosomal change seen in adults, and no specific prenatal, parental, or early-life exposure has been established as a cause. This reinforces that pediatric CML is not the result of anything a parent did or did not do.
Who Is Most at Risk?
From a population standpoint, the groups most associated with CML are older adults and people with a history of high-dose radiation exposure. Outside of these two factors, most people diagnosed with CML had no identifiable risk indicator beforehand.
Because CML can develop without warning, unexplained and persistent symptoms such as fatigue, night sweats, or unintended weight loss are worth discussing with a doctor, since CML is often found through blood testing done for another reason.
Key Causes and Risk Factors at a Glance
| Factor Type | Description | Strength of Association |
|---|---|---|
| Genetic abnormality | Acquired BCR-ABL1 fusion gene (Philadelphia chromosome) in bone marrow cells | Strong — present in over 95% of cases |
| Age | Median age at diagnosis is 67; uncommon before middle age | Moderate |
| Radiation exposure | High-dose ionizing radiation, such as prior radiation therapy | Low to moderate — most patients have no history of exposure |
| Family history | Inherited risk from relatives | None identified — the change is not inherited |
| Lifestyle factors | Diet, smoking, physical activity | Not on NCI’s recognized risk factor list |
FAQs About Causes and Risk Factors for Chronic Myeloid Leukemia
What kind of cellular change leads to chronic myeloid leukemia?
CML begins when part of chromosome 9 trades places with part of chromosome 22, fusing the ABL1 and BCR genes into a single abnormal gene on what is called the Philadelphia chromosome. This fusion gene produces a protein that stays switched on, pushing bone marrow cells to keep dividing. Because the affected cells still mature to a degree, the disease often progresses slowly in its early phase.
How does chronic myeloid leukemia develop in children?
In children, CML arises from the same BCR-ABL1 genetic change seen in adults, and it is not linked to anything during pregnancy, parenting, or early-life environment. Pediatric CML is rare and considered sporadic, meaning it occurs without a predictable trigger; researchers have not identified childhood-specific exposures that explain why it develops at a young age.
Can chronic myeloid leukemia occur without any known risk factors?
Yes. Most people diagnosed with CML have no history of radiation exposure or any other identifiable risk factor. The BCR-ABL1 change can occur as a random event during normal cell division, which is why CML is often discovered incidentally, through blood testing done for an unrelated reason, rather than through targeted screening.
Sources
